141 related articles for article (PubMed ID: 18225587)
1. The histone deacetylase inhibitor butyrate inhibits melanoma cell invasion of Matrigel.
Kuwajima A; Iwashita J; Murata J; Abe T
Anticancer Res; 2007; 27(6B):4163-9. PubMed ID: 18225587
[TBL] [Abstract][Full Text] [Related]
2. Alpha-melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells.
Murata J; Ayukawa K; Ogasawara M; Fujii H; Saiki I
Invasion Metastasis; 1997; 17(2):82-93. PubMed ID: 9561027
[TBL] [Abstract][Full Text] [Related]
3. Effects of histone deacetylase inhibitors on estradiol-induced proliferation and hyperplasia formation in the mouse uterus.
Gunin AG; Kapitova IN; Suslonova NV
J Endocrinol; 2005 Jun; 185(3):539-49. PubMed ID: 15930180
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of matrix-invasive potential of human liver cancer cells by type I interferon and a histone deacetylase inhibitor sodium butyrate.
Kaneko F; Saito H; Saito Y; Wakabayashi K; Nakamoto N; Tada S; Suzuki H; Tsunematsu S; Kumagai N; Ishii H
Int J Oncol; 2004 Apr; 24(4):837-45. PubMed ID: 15010820
[TBL] [Abstract][Full Text] [Related]
5. Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity.
Komatsu Y; Tomizaki KY; Tsukamoto M; Kato T; Nishino N; Sato S; Yamori T; Tsuruo T; Furumai R; Yoshida M; Horinouchi S; Hayashi H
Cancer Res; 2001 Jun; 61(11):4459-66. PubMed ID: 11389076
[TBL] [Abstract][Full Text] [Related]
6. Autocrine motility factor signals integrin-mediated metastatic melanoma cell adhesion and invasion.
Timar J; Trikha M; Szekeres K; Bazaz R; Tovari J; Silletti S; Raz A; Honn KV
Cancer Res; 1996 Apr; 56(8):1902-8. PubMed ID: 8620512
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors up-regulate the expression of tight junction proteins.
Bordin M; D'Atri F; Guillemot L; Citi S
Mol Cancer Res; 2004 Dec; 2(12):692-701. PubMed ID: 15634758
[TBL] [Abstract][Full Text] [Related]
8. Suppression of caspase-11 expression by histone deacetylase inhibitors.
Heo H; Yoo L; Shin KS; Kang SJ
Biochem Biophys Res Commun; 2009 Jan; 378(1):79-83. PubMed ID: 19013432
[TBL] [Abstract][Full Text] [Related]
9. Impairment of the metastatic activity of melanoma cells by transglutaminase-catalyzed incorporation of polyamines into laminin and Matrigel.
Lentini A; Provenzano B; Caraglia M; Shevchenko A; Abbruzzese A; Beninati S
Amino Acids; 2008 Feb; 34(2):251-6. PubMed ID: 17356804
[TBL] [Abstract][Full Text] [Related]
10. Regulation of adipocyte differentiation by histone deacetylase inhibitors.
Kim SN; Choi HY; Kim YK
Arch Pharm Res; 2009 Apr; 32(4):535-41. PubMed ID: 19407971
[TBL] [Abstract][Full Text] [Related]
11. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
Sekhavat A; Sun JM; Davie JR
Biochem Cell Biol; 2007 Dec; 85(6):751-8. PubMed ID: 18059533
[TBL] [Abstract][Full Text] [Related]
12. [4-acetamidophenyl retinoate (4-APR) inhibits reconstituted basement membrane invasion by tumor cells and its mechanism].
Shi B; Han R
Zhonghua Zhong Liu Za Zhi; 1997 May; 19(3):196-9. PubMed ID: 10920895
[TBL] [Abstract][Full Text] [Related]
13. A new in vitro assay for quantitating tumor cell invasion.
Repesh LA
Invasion Metastasis; 1989; 9(3):192-208. PubMed ID: 2722434
[TBL] [Abstract][Full Text] [Related]
14. Telomerase expression and cell proliferation in ovarian cancer cells induced by histone deacetylase inhibitors.
Zhu K; Qu D; Sakamoto T; Fukasawa I; Hayashi M; Inaba N
Arch Gynecol Obstet; 2008 Jan; 277(1):15-9. PubMed ID: 17680259
[TBL] [Abstract][Full Text] [Related]
15. Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase.
Dion LD; Goldsmith KT; Tang DC; Engler JA; Yoshida M; Garver RI
Virology; 1997 May; 231(2):201-9. PubMed ID: 9168882
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors promote neurosteroid-mediated cell differentiation and enhance serotonin-stimulated brain-derived neurotrophic factor gene expression in rat C6 glioma cells.
Morita K; Gotohda T; Arimochi H; Lee MS; Her S
J Neurosci Res; 2009 Aug; 87(11):2608-14. PubMed ID: 19360904
[TBL] [Abstract][Full Text] [Related]
17. [Anti-invasive and anti-metastatic effect of ampelopsin on melanoma].
Zheng HQ; Liu DY
Ai Zheng; 2003 Apr; 22(4):363-7. PubMed ID: 12703989
[TBL] [Abstract][Full Text] [Related]
18. Decreased syndecan-2 expression correlates with trichostatin-A induced-morphological changes and reduced tumorigenic activity in colon carcinoma cells.
Kim Y; Park H; Lim Y; Han I; Kwon HJ; Woods A; Oh ES
Oncogene; 2003 Feb; 22(6):826-30. PubMed ID: 12584561
[TBL] [Abstract][Full Text] [Related]
19. [Effects of ampelopsin on invasion and metastasis of B16 mouse melanoma in vivo and in vitro].
Liu DY; Zheng HQ; Luo GQ
Zhongguo Zhong Yao Za Zhi; 2003 Oct; 28(10):957-61. PubMed ID: 15620188
[TBL] [Abstract][Full Text] [Related]
20. Mel-CAM-specific genetic suppressor elements inhibit melanoma growth and invasion through loss of gap junctional communication.
Satyamoorthy K; Muyrers J; Meier F; Patel D; Herlyn M
Oncogene; 2001 Aug; 20(34):4676-84. PubMed ID: 11498790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
